|
Brigatinib Clinical Trials
3 actively recruiting trials
Also known as: ALUNBRIG, Alunbrig, Alunbrig Tablets
Pipeline
Phase 1/2: 1
Top Sponsors
- Takeda1
- Princess Maxima Center for Pediatric Oncology1
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Indications
- Cancer3
- Lung Cancer2
- Sex Disorder1
- Other Solid Tumor1
- Inflammatory Myofibroblastic Tumor1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.